Build status - In Progress

Observational study of COVID-19 vaccine responses in patients with autoimmune diseases

Recruiting
18 years - 99 years
All
115 participants needed
1 Location

Brief description of study

Adult patients with Rheumatoid Arthritis, Psoriatic Arthritis, SLE, Sjogren’s Disease, Multiple Sclerosis, Scleroderma, Vasculitis or Blistering Diseases will undergo a blood draw and collection of clinical information prior to receipt of COVID-19 vaccination. Subjects will undergo a repeat blood draw and collection of clinical information at 4-10 weeks, 6 months and 12 months following their second vaccination (or 8-12 weeks after single vaccination for vector based vaccine).

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: Rheumatoid Arthritis, Psoriatic Arthritis, SLE, Sjogren’s Disease, Multiple Sclerosis, Scleroderma, Vasculitis or Blistering Diseases
  • Age: 18 years - 99 years
  • Gender: All

Male or Female, Age 18 or older, Obtaining Covid-19 vaccine.

Updated on 04 Aug 2024. Study ID: 850219

Find a site

We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Preferred way of contact
Race
Ethnicity
Other language

Interested in the study

Select a study center that’s convenient for you, and get in touch with the study team.

Contact a study center